CABA

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bronchiectasis1 trial
• Ovarian cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials

Lead sponsor

• GlaxoSmithKline2 trials

Running trials

• Recruiting

  Mo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]

  NCT07694427· Phase 3· GlaxoSmithKline· Source

  Contact: Naima Kassis (principal investigator)

• Recruiting

  A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

  NCT07201051· Phase 2· GlaxoSmithKline· Source

  Contact: Abel Bordon (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bronchiectasis1 recruiting
• Ovarian cancer1 recruiting